CN109925504A - A kind of drug for improving enteron aisle and preparation method thereof and application method - Google Patents
A kind of drug for improving enteron aisle and preparation method thereof and application method Download PDFInfo
- Publication number
- CN109925504A CN109925504A CN201910298387.6A CN201910298387A CN109925504A CN 109925504 A CN109925504 A CN 109925504A CN 201910298387 A CN201910298387 A CN 201910298387A CN 109925504 A CN109925504 A CN 109925504A
- Authority
- CN
- China
- Prior art keywords
- drug
- enteron aisle
- improving
- preparation
- application method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A kind of drug for improving enteron aisle and preparation method thereof and application method, the invention belongs to field of medicaments, intestinal environment can be improved to provide kind, and then adjust the drug of body, it is a kind of for improving the drug of enteron aisle, the drug includes that weight ratio is (2-3): the good protein and oligofructose of (2-3).The beneficial effects of the present invention are: 1, low sugariness, low in calories is highly suitable for diabetic and overweight people takes；2, serum cholesterol level is reduced, High-density Lipoprotein-cholesterol is improved；3, relax bowel and defecation increases intestinal beneficial bacterium by the proliferation of Bifidobacterium, inhibits harmful bacteria；4, strengthen immunity improves cancer suppressing action.5, beauty, weight-reducing, exquisiteness, lubrication, flexible skin.
Description
Technical field
The invention belongs to field of medicaments, specifically a kind of drug for improving enteron aisle and preparation method thereof and make
Use method.
Background technique
Intestines health problem, situations such as meaning just knot, constipation, diarrhea, anorexia, it is few that bowel problem is attributed to beneficial bacterium,
Caused by harmful bacteria is more.Increase the beneficial bacterium in intestines, reduce the quantity of harmful bacteria, is that medical field is endeavoured always
In solving the problems, such as and perfect, medical field pays very big effort thus, and currently used method swallows viable bacteria, yogurt, benefit
Raw member etc., but effect is little, and because all viable bacterias can not be by stomach, under the gastric juice effect of highly acid, viable bacteria is can not
Existence, intestines also can not be just reached, its effect can not be played.Therefore it provides one kind can improve intestinal environment, and then adjust
The drug of whole body is necessary.
Summary of the invention
Mentioned above to solve the problems, such as, the present inventor provides a kind of the following technical solution:
It is a kind of for improving the drug of enteron aisle, the drug includes that weight ratio is (2-3): the high-quality protein of (2-3)
Matter and oligofructose.
Specifically, good protein 400g~600g
Oligofructose 600g~400g.
Oligofructose is to be produced and obtained with transfructosylase, it is flat with bidirectional modulation Tiny ecosystem using sucrose as raw material
The Zheng Chang Sheng of weighing apparatus manages function.It can make Bifidobacterium, Bacillus acidi lactici proliferation, and perfringens bacillus is made to be suppressed or not be proliferated,
Make Escherichia coli or enterococcus, bacteroid is not proliferated or is proliferated amplitude and is proliferated lower than Bifidobacterium or lactobacillus, absorbs oligomeric fruit
After sugar, enteral Bifidobacterium can increase by hundreds times, reach the function of adjusting gastrointestinal bacterial flora.
Good protein is the replenishers and regulator of people's cell, it is suppressed that the harmful bacteria in enteron aisle restores human body
Normal metabolism, that is, can reach, healthy tendency memory, the boundary that heresy can not be done.
Kang Si get albumen powder is to belong to high-quality protein powder, it is the ingredient 83% using people lactoprotein's matter structure as object of reference
Above with people lactoprotein's matter coincide and the application use oleosin powder.
It is a kind of for improving the preparation method of the drug of enteron aisle, in proportion by above-mentioned good protein and oligofructose
It after weighing, mixes well, 80 DEG C of drying, sterilizing is packed to obtain the final product.
It is a kind of for improving the application method of the drug of enteron aisle, the application method is that 3 times a day, need to take 10 every time
~15g.
People is by cell composition, sum about 60,000,000, about 500,000, the cell of death each second, if cannot give in time
Supplement, is bound to cause immunity degradation, and organ failure etc. influences health.Especially under the action of FOS, people's is new old
Be metabolized it is vigorous, if sufficient supplement good protein not in time, so will cause the various discomforts of body for a long time.
The combination of FOS and good protein is reasonably, after releasing enteron aisle discomfort, to adjust systemic organ.
The beneficial effects of the present invention are:
1, low sugariness, low in calories, is highly suitable for diabetic and overweight people takes；
2, serum cholesterol level is reduced, High-density Lipoprotein-cholesterol is improved；
3, relax bowel and defecation increases intestinal beneficial bacterium by the proliferation of Bifidobacterium, inhibits harmful bacteria, restores enteron aisle
Due vigor, so that situations such as overcoming just knot, constipation, diarrhea, anorexia, achievees the effect that relax bowel and defecation.
4, strengthen immunity improves cancer suppressing action.Beneficial bacterium mass propagation in enteron aisle, cell, cell wall constituent and thin
Mucilage secretion improves the intracorporal immunity of machine, and good protein has the function of repair cell, to make intracorporal immune
Cell maintains certain level, inhibits the occurrence and development of cancer.
5, beauty, weight-reducing, exquisiteness, lubrication, flexible skin, science prove that comfortable stomach is the basic of physical and mental health
Condition, beautiful skin and comfortable stomach have close relationship.The quantity of Bifidobacterium is direct reaction stomach
The barometer of health.In infant's enteron aisle, beneficial bacterium has overwhelming superiority, and harmful bacteria only accounts for 5% or less the total bacterium amount of stomach.
Here it is the skin of infant lubrication, one of the reason of high resilience, then it is subject to good protein, keeps the full of blood, flesh
The stalwartness of meat can improve skin and body.
Specific embodiment
With reference to embodiment, further invention is made to the present invention and explains.
| Good protein | Oligofructose | |
| Embodiment 1 | 400g | 600g |
| Embodiment 2 | 600g | 400g |
| Embodiment 3 | 500g | 500g |
After two kinds of raw materials weighing in above-mentioned 3 embodiments, sets in mixing machine, mix well, be placed in stainless steel disc
In, 80 DEG C of drying, sterilizing is fitted into can or is packed with aluminium plastic bag, then, after chemical examination is qualified, is put in storage to obtain the final product.
Development work of the invention, since in March, 2015, because of part patient comrade Liu of in September, 2014, through curing
Institute checks, suffers from intestinal polyp, and hospital requirements are hospitalized at once and have an operation, and inventor analyzed its situation in earnest at that time, it is believed that: 1,
Polyp is removed with Chinese medicine；2, increase intestinal beneficial bacterium, it should which helpful for early stage intestinal cancer (intestines polyp is exactly early stage intestines
Cancer, referred to as intestines submucosal glands tumour, there is canceration trend), effect should be more preferable than performing the operation.Miss Liu takes one month
After Chinese medicine, polyp is disappeared, and 14 years so far, the case where recurrence.Then adhere to daily 20~30gFOS protein mouth
Clothes solve constipation, just knot etc., and keep clear state at any time.
Chen, female, 85 years old, obstinate elderly constipation patient, continuously take 4 months so far, onset time about 3~4
The phenomenon that it, all goes well now, constipation, loose stool all disappears.
Lee, female, 61 years old, long-term constipation patient are the loyal users of " enema ", are continuously taken about 5 days, and are arrived
It is modern unblocked, break off relationship with medicine friend " enema ".
Lee, female, 63 years old, stomach angle tumour, polyp of colon have met no danger after taking 1 month Chinese medicine and this product.
Mr. Hu in Sichuan Chengdu, 63 years old, private prosecution intestines sense of discomfort had 3~4 years, and constipation, is alternately produced loose stool.Doctor
Suspection is intestinal cancer, but result of laboratory test is without cancer index.Try out the kind from June, 2016, continuous 6 months, intestines so far
Above-mentioned phenomenon all disappear.
Claims (4)
1. a kind of for improving the drug of enteron aisle, which is characterized in that the drug includes that weight ratio is (2-3): (2-3's)
Good protein and oligofructose.
2. as described in claim 1 for improving the drug of enteron aisle, which is characterized in that the good protein refer to
People lactoprotein's matter structure is object of reference, and 83% or more ingredient and people lactoprotein's matter are coincide.
3. a kind of for improving the preparation method of the drug of enteron aisle, which is characterized in that by high-quality egg of any of claims 1 or 2
It after white matter and oligofructose are weighed in proportion, mixes well, 80 DEG C of drying, sterilizing is packed to obtain the final product.
4. as claimed in claim 1 or 2 a kind of for improving the application method of the drug of enteron aisle, which is characterized in that described
Application method is that 3 times a day, need to take 10~15g every time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910298387.6A CN109925504A (en) | 2019-04-15 | 2019-04-15 | A kind of drug for improving enteron aisle and preparation method thereof and application method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910298387.6A CN109925504A (en) | 2019-04-15 | 2019-04-15 | A kind of drug for improving enteron aisle and preparation method thereof and application method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109925504A true CN109925504A (en) | 2019-06-25 |
Family
ID=66990013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910298387.6A Pending CN109925504A (en) | 2019-04-15 | 2019-04-15 | A kind of drug for improving enteron aisle and preparation method thereof and application method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109925504A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496575A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special nutrient foodstuffs formula containing small peptide and probiotics |
| CN104544401A (en) * | 2015-01-03 | 2015-04-29 | 保龄宝生物股份有限公司 | Protein solid drink suitable for diabetic patients |
| CN106720456A (en) * | 2017-01-10 | 2017-05-31 | 西藏文殊生物科技有限公司 | Solid beverage composition containing WPC and preparation method thereof |
| CN109198028A (en) * | 2017-06-30 | 2019-01-15 | 况代武 | A kind of compound protein powder nutritional food formula containing lactoferrin |
-
2019
- 2019-04-15 CN CN201910298387.6A patent/CN109925504A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496575A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special nutrient foodstuffs formula containing small peptide and probiotics |
| CN104544401A (en) * | 2015-01-03 | 2015-04-29 | 保龄宝生物股份有限公司 | Protein solid drink suitable for diabetic patients |
| CN106720456A (en) * | 2017-01-10 | 2017-05-31 | 西藏文殊生物科技有限公司 | Solid beverage composition containing WPC and preparation method thereof |
| CN109198028A (en) * | 2017-06-30 | 2019-01-15 | 况代武 | A kind of compound protein powder nutritional food formula containing lactoferrin |
Non-Patent Citations (1)
| Title |
|---|
| 康思得蛋白质: "康思得FOS蛋白质", 《CONCEPT康思得》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Amabebe et al. | Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism | |
| Vallianou et al. | Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives | |
| Blaak et al. | Short chain fatty acids in human gut and metabolic health | |
| Ipar et al. | Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children | |
| Caballero-Franco et al. | The VSL# 3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | |
| Rolim | Development of prebiotic food products and health benefits | |
| Soldavini et al. | Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity | |
| TWI463986B (en) | New use of lactobacillus plantarum cmu995 strain | |
| CN104413334A (en) | Edible composition as well as preparation method and application thereof | |
| Dreyer et al. | Early colonization of the gut microbiome and its relationship with obesity | |
| CN105985918B (en) | Anti-obesity lactic acid bacteria strain and application thereof in food composition and medical composition | |
| CN104415060A (en) | Edible composition as well as preparation method and application thereof | |
| CN104489462A (en) | Xylooligosaccharide probiotic powder | |
| Althubiani et al. | Plant-derived prebiotics and its health benefits | |
| Sheykhsaran et al. | Gut microbiota and obesity: an overview of microbiota to microbial-based therapies | |
| Yang et al. | Variations on gut health and energy metabolism in pigs and humans by intake of different dietary fibers | |
| Wu et al. | Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases | |
| Santos et al. | Blenderized formulations in home enteral nutrition: A narrative review about challenges in nutritional security and food safety | |
| Noor et al. | Exploring the impact of the gut microbiome on obesity and weight loss: a review article | |
| CN110075226A (en) | It is a kind of can be with the probiotic composition of reducing blood lipid | |
| Ahmad et al. | The gut microbiome in the fight against obesity: The potential of dietary factors | |
| CN109925504A (en) | A kind of drug for improving enteron aisle and preparation method thereof and application method | |
| WO2023284778A1 (en) | Prebiotic composition and use thereof | |
| Dreher et al. | Connection between fiber, colonic microbiota, and health across the human life cycle | |
| Annapure et al. | Role of gut microbiome in obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |